Clinical and Genetic Studies of Three Inherited Skeletal Disorders

Clinical and Genetic Studies of Three Inherited Skeletal Disorders

UMEÅ UNIVERSITY MEDICAL DISSERTATIONS New Series No. 1259 ISSN 0346-6612 ISBN 978-91-7264-753-4 Clinical and Genetic Studies of Three Inherited Skeletal Disorders Eva-Lena Stattin From the Department of Medical Biosciences Medical and Clinical Genetics Umeå University SE-901 85 Umeå Sweden 2009 Copyright© 2009 by Eva-Lena Stattin New Series No. 1259 ISBN: 978-91-7264-753-4 ISSN: 0346-6612 Cover: Pedigree, familial osteochondritis dissecans Printed by: Hemströms tryckeri, Härnösand, Sweden 2009 To Pär, Kalle and Oskar 3 Contents CONTENTS .......................................................................................................................4 PUBLICATIONS...............................................................................................................6 THESIS AT A GLANCE ..................................................................................................7 ABSTRACT .......................................................................................................................8 ABBREVIATIONS............................................................................................................9 M0B EDICAL GENETICS ............................................................................................ 11 Human28B genome................................................................................................................. 11 DNA29B structure...................................................................................................................11 Characteristics30B of Mendelian inheritance.......................................................................... 11 Inter31B individual variations................................................................................................. 12 INTRODUCTION ...........................................................................................................14 The15B Skeleton................................................................................................ 14 Extracellula16B r matrix ...................................................................................... 14 Cartila17B ge....................................................................................................... 15 C1B OMPONENTS OF THE EXTRACELLULAR MATRIX NETWORK.................................... 16 The18B large aggregating Proteoglycans.......................................................... 16 ACAN-gene19B and Aggrecan .......................................................................... 16 Molecular32B gene structure, organization and function........................................................ 16 C2B HONDRODYSPLASIAS DUE TO AGGRECAN DEFECTS............................................. 18 C3B HONDRODYSPLASIAS DUE TO AGGRECAN DEFECTS - ANIMAL MODELS ................. 19 Cartilage3B matrix deficiency............................................................................................... 19 Cartilage34B matrix deficiency-Bc......................................................................................... 19 Nanomelia......................................................................................................................35B ... 19 Bulldog36B dwarfism ............................................................................................................. 19 C4B HONDRODYSPLASIAS DUE TO AGGRECAN DEFECTS – HUMAN DISORDERS............ 20 Spondyloepiphyseal37B dysplasia type Kimberley (SEDK)................................................... 20 Spondyloepimetaphyseal38B dysplasia (SEMD-aggrecan-type) ............................................ 20 Familial39B osteochondritis dissecans.................................................................................... 20 Disorders associated with defective sulfation of proteoglycans .................. 21 Degenerative20B diseases involving aggrecan ................................................. 21 VNTR-region40B of the ACAN-gene and OA ....................................................................... 21 Age-related41B changes of aggrecan...................................................................................... 22 C5B OMPONENTS OF THE EXTRACELLULAR MATRIX NETWORK.................................... 22 The42B Collagens...................................................................................................................22 CHONDRODYSPLASIA DUE TO DEFECTS IN ECM-PROTEINS ................................... 23 Multiple43B epiphyseal dysplasia........................................................................................... 23 SKELETONENESIS ............................................................................................... 23 The2B Indian Hedgehog (IHH)-gene; an important gene for skeletal development................................................................................................. 24 Brachydactyly4B type A1 ..................................................................................................... 25 AIMS OF THE THESIS .................................................................................................26 4 METHODOLOGY ..........................................................................................................27 Ethics.........................................................................................................................45B ....... 27 Introduction23B to field work .............................................................................. 27 Collecting46B clinical material............................................................................................... 27 Evaluation47B of suspected skeletal dysplasias...................................................................... 27 Field24B work..................................................................................................... 27 Study48B I and II (Familial OCD).......................................................................................... 27 Study49B III (MED) ............................................................................................................... 28 Study50B IV (BDA1).............................................................................................................. 28 Methods25B ....................................................................................................... 29 Statistical51B analysis............................................................................................................. 29 Linkage52B analysis ............................................................................................................... 29 Molecular26B genetics methods ........................................................................ 29 DNA53B extraction................................................................................................................. 29 PCR .................................................................................................................................. 29 Genome-wide54B scan ........................................................................................................... 30 Sequencing/Candidate5B gene analysis ................................................................................ 30 Interpretation56B of identified variations ............................................................................... 31 DHPLC..........................................................................................................................57B ... 31 Restriction58B endonuclease digestion of the PCR product ................................................... 32 Protein59B interaction analysis............................................................................................... 32 Mass60B spectrometry............................................................................................................ 33 RESULTS AND DISCUSSION ......................................................................................34 P7B APER I ............................................................................................................. 34 P8B APER II ............................................................................................................ 36 P9B APER III ........................................................................................................... 39 P10B APER IV ........................................................................................................... 41 Concluding27B remarks and future perspectives .............................................. 43 POPULÄRVETENSKAPLIG SAMMANFATTNING PÅ SVENSKA ......................44 I1B NTRODUKTION ................................................................................................... 44 M12B ANUSKRIPT I & II .............................................................................................. 44 M13B ANUSKRIPT III .................................................................................................. 45 M14B ANUSKRIPT IV.................................................................................................. 46 ACKNOWLEDGEMENTS ............................................................................................47 REFERENCES ................................................................................................................49 5 Publications This thesis is based on the following original publications, which will be referred to by their roman numerals:

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    55 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us